XXX Congreso Nacional
09 al 07 de Noviembre de 2014
Hotel Hesperia World Trade Center
Valencia - Edo. CaraboboXXXI Congreso Nacional
30 de Junio al 03 de Julio de 2015
Hotel Hesperia World Trade Center

Jul - Aug 2015 / Vol. 1 / Isuue 4
Sep - Oct 2017 / Vol. 3 / Isuue 5


Keystone Symposia: Vectors, Pathogens and Diseases Keystone Symposia: Vectors, Pathogens and Diseases
Facebook iconTwitter icon
Antimicrobial Resistance, Oct 29-Nov 1, 2017, Santa Fe, NM, USA
Antimicrobial-resistant (AMR) infections claim hundreds of thousands of lives around the globe annually. This problem is exacerbated by a steady increase in global antimicrobial use and abuse in the clinic and agriculture, and a dearth of novel antimicrobials making it to market. If these scenarios continue unchecked, AMR will cumulatively cost the global economy at least 100 trillion dollars by 2050. 

This three-day conference will focus on the latest work understanding and combatting AMR, incorporating clinical perspectives on AMR diagnostics and management, translational academic perspectives on design of drug regimens and combinations that suppress AMR, pharma perspectives on recent successes and failures in novel antimicrobial development and clinical trials, and basic science perspectives on the ecology and transmission of evolving AMR determinants. While these stakeholders are similarly motivated to identify and develop therapies to treat the exceptional, unmet medical need of worsening AMR, their spheres rarely overlap at scientific conferences, leading to scientific communication barriers between subject matter experts. This conference attempts to address this challenge by engaging diverse global perspectives on these topics, bringing together speakers and attendees from research academia, industrial drug development, and healthcare practice and policy. In summary, key goals are to:
  • Present and discuss the most current and cutting-edge results regarding understanding and combatting antimicrobial resistance, including presentation of the newest technologies, experimental approaches, and policy initiatives, as well as discussions of how to speed their translation and clinical implementation;
  • Address current controversies that may slow progress in the field, and consider future directions, including identification of the most pressing unanswered questions, the areas needing more focus, and those that would benefit from new approaches and methodologies;
  • Bridge the gap between scientists from the academic research arena, pharma/industrial drug development, and healthcare practice and policy.
Hear the following confirmed speakers (additional speakers will be added, including short talks chosen from abstracts):
Paul Ambrose, Institute for Clinical Pharmacodynamics, USA
Gavin Barlow, Hull and East Yorkshire Hospitals, NHS Trust and University of York, UK
Ilana L. Brito, Cornell University, USA
Carey-Ann D. Burnham, Washington University School of Medicine, USA
Karen Bush, Indiana University, USA
Lynn Connolly, Achaogen, USA
Gautam Dantas, Washington University School of Medicine, USA
Thomas F. Durand-Reville, Entasis Therapeutics, USA
Danica Galonic Fujimori, University of California, San Francisco, USA
Lorraine D. Hernandez, Merck Research Laboratories, USA
Kathryn E. Holt, University of Melbourne, Australia
Scott Hultgren, Washington University School of Medicine, USA
Ramanan Laxminarayan*, Center for Disease Dynamics, Economics and Policy, India
Jean Patel, Centers for Disease Control and Prevention, USA
Folkert Reck, Novartis Institutes for BioMedical Research, USA
Aileen Rubio, Spero Therapeutics, USA
Paolo Ruggerone, Università degli studi di Cagliari, Italy
Gerry D. Wright, McMaster University, Canada
Pamela Yeh, University of California, Los Angeles, USA
Helen I. Zgurskaya, University of Oklahoma, USA 

*Keynote Speaker
Oct 29 ? Nov 1, 2017
Eldorado Hotel
Santa Fe, New Mexico, USA 

Scientific Organizers:
Gautam Dantas, Washington University School of Medicine
Jennifer A. Leeds, Novartis Institutes for BioMedical Research

Submit AbstractApply for Scholarship
Submit AbstractSubmit Abstract


? Surveillance and Treatment of Resistant Bacterial Infections in Clinical Practice
? Workshop 1: Novel Therapeutic Strategies
? Fate and Lessons Learned from Recent Drug Development Programs Focused on Resistant Pathogens or Narrow-Spectrum Agents
? Alternative Approaches to Tackling Resistant Infections
? Multidrug Evolutionary Strategies to Invert Resistance Selection
? Ecology and Evolution of AMR Transmission Dynamics Across Habitats
? Workshop 2: Novel Strategies for AMR Discovery, Diagnostics and Modeling
? Tackling AMR ? Challenges in Drug Development


Scholarship Application:
June 27, 2017

Discounted Abstract Submission:
June 27, 2017

Abstract Submission:
July 27, 2017

Discounted Registration:
August 29, 2017
Who should attend?
Biochemists ? Clinicians ? Drug Developers ? Epidemiologists ? Infectious Disease Specialists ? Medicinal Chemists ? Microbiologists

We thank PLOS for their in-kind marketing/advertising support of this meeting:

Additional Information
  • Click here to view the program and click here to download a program flyer.
  • Deadlines are at midnight US Mountain Time.
  • Discounted abstract submission and discounted registration save 50 USD and 200 USD, respectively, on later fees.
  • Presenting a poster is an excellent way to gain feedback on your work. Abstracts can be submitted through the discounted registration deadline for poster presentation, but those submitted by the abstract deadline will also be considered for short talk selection.
  • Please note that the first advertised meeting date is the date of arrival and registration, and the last date that of the last organized sessions.


Update your account details | Unsubscribe

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization headquartered in Colorado, USA that is directed and supported by the scientific community.
160 US Highway 6, Suite 200 | PO Box 1630 | Silverthorne, CO 80498 | USA
1-970-262-1230 | 1-800-253-0685 (in US & Canada)

Dear Colleague, 

The 2017-2018 Keystone Symposia conference season is about to begin, and I want to bring to your attention the following conferences, that according to our records, you may find of interest. Each conference name below is linked to the meeting webpage where you can find more details regarding the program and speakers, plus the discounted registration, abstract and scholarship deadlines. 

The 2018 conferences in our Immunology series are:
More information about all of our 2018 conferences can be found on our website at

Whether or not you can personally attend an upcoming Keystone Symposia conference, please spread the word about our conference season among your network of colleagues, and especially students and postdocs as the participation of early-career investigators is vital, and we offer scholarships to help defray their costs. 

I welcome any email regarding our conferences or feedback on other Keystone Symposia-related topics. I am very proud of the Keystone Symposia staff and advisors and the outstanding programs we convene each year. We are always open to new ideas and suggestions. 

I hope you will find time in the next year to attend one of the exciting symposia and that I might meet you face-to-face at a 2018 conference! 

Thank you for your time and best regards, 

Jane L. Peterson, Ph.D.
President and Chief Executive Officer
+ 1 970-262-2694 | 

Keystone Symposia on Molecular and Cellular Biology
Accelerating Life Science Discovery
Celebrating Diversity 2016-2018
Silverthorne | Colorado 80498 | USA
Phone: +1 970-262-1230 | + 1-800-253-0685
Fax: +1 970-262-1525 | Website: 

Follow us on Facebook, Twitter and YouTube:


Avanced Life Support in Obstetrics

Soporte Vital Avanzado en Obstetricia Propuesta para disminuir Mortalidad Materna

Soporte Vital Avanzado en Obstetricia...


Zika y Embarazo. La SOGV informa
- FIGO Zika may be responsible for many deformities, say scientists- FIGO First baby with Zika-related microcephaly born in Guatemala
- FIGO Statem...




JULIO 2016

JUNIO 2016

MAYO 2016


ABRIL 2016

MARZO 2016


ENERO 2016






through technology



JULIO 2015

JUNIO 2015

MAYO 2015

ABRIL 2015

MARZO 2015


ENERO 2015






JULIO 2014

JUNIO 2014

Insertar Texto aquiInsertar Texto aquiInsertar Texto aquiInsertar Texto aquiInsertar Texto aquiInsertar Texto aquiInsertar Texto aquiInsertar Texto aqui

Noviembre 2013

Gaceta Oficial Nº 39.823 del 19 de diciembre de 2011 Ley de Ejercicio de la Medicina - (PDF)...

Summary Guidance for Acute 
Trust Staff: Frequently 
asked questions (FAQs) 
on Ebola for Infection Control and Prevention staffEbola Virus DiseaseInformation for healthcare workers: 
Ebola in ...

-     ABORTO TALLER. (Dra. Luisa Obregón)   -     Métodos de tratamiento. (Dr. Williams Sánchez)   -     Anticoncepción posterior a evento obstétrico....

Salud Sexual y Reproductiva
Transdermal ContraceptionInduced Abortion: Epidemiologic AspectsContraceptive Efficacy
EditorialINTRODUCCION A CURSO AMEOLey Organica Violencia UNFPAManejo de AbortoCuidados  de...

Human Papillomavirus Vaccination
SOGV y la Vacuna de VPH
HPV supplement -FIGO
Declaración de FIGO sobre la Seguridad de la Vacunación del VPH, Agosto 2, 2013
New HPV vaccine ?could prevent 90% of ce...


   Educación sexual para adolesentes      Salud sexual de la mujer     Sexualidad clínica...